N-phenyl-N-formylglycine ethyl ester | 54915-69-4

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: N-phenyl-N-formylglycine ethyl ester
• 英文别名: N-formyl-N-phenyl-glycine ethyl ester；N-Formyl-N-phenyl-glycin-aethylester；Formylanilinoessigsaeure-aethylester；N-Formyl-N-phenyl-glycinaethylester；ethyl 2-(N-phenylformamido)acetate；ethyl 2-(N-formylanilino)acetate
• CAS: 54915-69-4
• 化学式: C₁₁H₁₃NO₃
• 分子量: 207.229
• InChiKey: DKQPASMMIHXYBL-UHFFFAOYSA-N

物化性质

• 沸点：
  115-117 °C(Press: 1 Torr)
• 密度：
  1.165±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  15
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  46.6
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  N-phenyl-N-formylglycine ethyl ester 在 硝酸 、 sodium nitrite 作用下， 生成 1-phenyl-1H-imidazole-4,5-dicarboxylic acid
  参考文献：
  名称：

  Studies on Imidazoles. V. The S-Alkylation of 2-Mercaptoimidazoles with Esters

  摘要：

  DOI：

  10.1021/ja01124a510
• 作为产物：
  描述：

  N-苯基氨基乙酸乙基醚 以 甲乙酐 为溶剂， 以70%的产率得到N-phenyl-N-formylglycine ethyl ester
  参考文献：
  名称：

  Bis(acyloxmethyl)imidazole compounds

  摘要：

  这项发明涉及新的双(酰氧甲基)咪唑衍生物；包括这些衍生物的组合物；以及作为杀菌剂、杀菌剂和抑制癌症生长的工具的过程，特别是固体肿瘤癌症，在温血动物中的公式：##STR1## 其中M是##STR2##或R；每个R、R'和R"独立地选自氢和Z取代或未取代的烷基、环烷基、环烯烃基、烯基、芳基和杂环戒指，其中所述环至少包括氧、氮、硫或硅中的一个；前提是##STR3##可以形成Z取代或未取代的杂环，并且连接到咪唑环的R'和R"可以形成Z取代或未取代的杂环；X选自氧、硫、氮和烷基中的至少一个；进一步提供的是硅不直接连接到氧、硫或氮，当X为氧或硫时，R'不是氢；Z选自卤素、硝基、腈基、烷基、卤代烷基、烯基、羧酸、羧酸酯、羧酸酰胺、醚、硫醚、羟基、酰化羟基、磺酰胺、磺酰脲、亚砜、砜、取代和未取代胺或其混合物。

  公开号：

  US05329012A1

文献信息

• Pyridopyridazine compounds and their use
  申请人：Takeda Chemical Industries, Ltd.

  公开号：US05420275A1

  公开（公告）日：1995-05-30

  An assay method which comprises utilizing chemiluminescence of a pyridopyridazine compound of the formula ##STR1## wherein R.sub.1 is a hydrocarbon group or a heterocyclic group each of which may be substituted and R.sub.2 is hydroxy group, thiol group, amino group or a monosubstituted amino group, and when R.sub.2 is a monosubstituted amino group, R.sub.2 may be taken together with R.sub.1 to form the ring; R.sub.3 is hydrogen atom, a hydroxy group which may be substituted, an amino group which may be substituted, a thiol group which may be substituted, a halogen atom, a heterocyclic group, nitro group, cyano group, carboxyl group which may be esterified or amidated, azido group, sulfo group or an organic sulfonyl group, provided that when R.sub.1 is an aliphalic group, R.sub.3 is not hydrogen atom; and X is oxygen atom or sulfur atom/or a salt thereof; and a novel compound of the formula (I) wherein the symbols are as defined above with proviso that R.sub.3 is hydrogen atom, R.sub.1 is a substituted aryl group or a heterocyclic group which may be substituted, or a salt thereof and the production methods thereof.

  一种测定方法，包括利用式子##STR1##中的吡啶吡嗪化合物的化学发光，其中R.sub.1是烃基或杂环基，可以被取代，R.sub.2是羟基、硫醇基、氨基或单取代氨基，当R.sub.2是单取代氨基时，R.sub.2可以与R.sub.1结合形成环；R.sub.3是氢原子、可以被取代的羟基、可以被取代的氨基、可以被取代的硫醇基、卤素原子、杂环基、硝基、氰基、可以酯化或酰胺化的羧基、偶氮基、磺酰基或有机磺酰基，但当R.sub.1是脂肪基时，R.sub.3不是氢原子；X是氧原子或硫原子/或其盐；以及式(I)的新化合物，其中符号如上定义，但R.sub.3是氢原子，R.sub.1是取代芳基或可以取代的杂环基或其盐，以及其生产方法。
• Isoxazole derivatives
  申请人：——

  公开号：US20040048908A1

  公开（公告）日：2004-03-11

  A compound represented by the formula (I) 1 wherein one of R 1 and R 2 is a hydrogen atom or a substituent and the other is an optionally substituted cyclic group; W is a bond or a divalent aliphatic hydrocarbon group; Y is a group of the formula: —OR 3 (wherein R 3 is a hydrogen atom, an optionally substituted hydrocarbon group, an optionally substituted heterocyclic group or an optionally substituted acyl group) or an optionally esterified or amidated carboxyl group, or a salt thereof or a prodrug thereof has a superior insulin secretion promoting action and a hypoglycemic action and shows low toxicity. Therefore, the compound is useful as a pharmaceutical agent, particularly as an agent for the prophylaxis or treatment of diabetes and diabetic complications, and the like.

  化合物的化学式为（I）1，其中R1和R2中的一个是氢原子或取代基，另一个是可选取代的环状基团；W是键或二价脂肪基碳氢基团；Y是式子：—OR3的基团（其中R3是氢原子、可选取代的碳氢基团、可选取代的杂环基团或可选取代的酰基基团），或可选酯化或酰胺化的羧基团，或其盐或前药。该化合物具有优异的促胰岛素分泌作用和降血糖作用，并且毒性低。因此，该化合物可用作制药剂，特别是用作糖尿病和糖尿病并发症的预防或治疗剂等。
• Bis (acyloxymethyl) imidazole Derivative
  申请人：THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK

  公开号：EP0313724A2

  公开（公告）日：1989-05-03

  This invention relates to new bis(acyloxymethyl)imidazole derivatives; to compositions comprising these derivatives: and to processes for their utility as fungicides, bactericides and as inhibitors of the growth of cancer, particularly solid tumor cancer, in warm blooded animals of the formula: wherein M is N < or R: each R, R', and R" are independently selected from hydrogen and Z substituted or unsubstituted alkyl, cycloalkyl, cycloalkenyi, alkenyl, aryl, and heterocyclic ring wherein said ring comprises at least one of oxygen, nitrogen, sulfur or silicon; provided that N < may form a Z substituted or unsubstituted heterocyclic, and R and R attached to the imidazole ring, may form a Z substituted or unsubstituted heterocyclic ring; X is selected from at least one of oxygen, sulfur, nitrogen and alkyl; provided further that silicon is not directly attached to oxygen, sulfur or nitrogen and R' is not hydrogen when X is oxygen or sulfur; and Z is selected from halogen, nitro, nitrile, alkyl, haloalkyl, alkenyl, carboxylic acid, carboxylic acid ester, carboxylic acid amide, ether, thioether, hydroxyl, acylated hydroxyl, sulfonylamide, sulfonylurea, sulfoxide, sulfone, substituted and unsubstituted amine or mixtures thereof.

  本发明涉及新的双(酰氧基甲基)咪唑衍生物；涉及包含这些衍生物的组合物；涉及它们作为杀真菌剂、杀细菌剂和作为癌症（尤其是实体瘤癌症）生长抑制剂在温血动物中的应用过程，其式如下： 其中 M 是 N < 或 R：每个 R、R'和 R "独立地选自氢和 Z 取代或未取代的烷基、环烷基、环烯基、烯基、芳基和杂环，其中所述环包括氧、氮、硫或硅中的至少一种；条件是 N < 可形成 Z 取代或未取代的杂环，而连接到咪唑环上的 R 和 R 可形成 Z 取代或未取代的杂环；X 选自氧、硫、氮和烷基中的至少一种；条件是硅不直接与氧、硫或氮相连，且当 X 为氧或硫时，R'不是氢；Z 选自卤素、硝基、腈、烷基、卤代烷基、烯基、羧酸、羧酸酯、羧酸酰胺、醚、硫醚、羟基、酰化羟基、磺酰酰胺、磺酰脲、亚砜、砜、取代和未取代的胺或它们的混合物。
• ISOXAZOLE DERIVATIVES
  申请人：Takeda Chemical Industries, Ltd.

  公开号：EP1340749A1

  公开（公告）日：2003-09-03

  A compound represented by the formula (I) wherein one of R1 and R2 is a hydrogen atom or a substituent and the other is an optionally substituted cyclic group; W is a bond or a divalent aliphatic hydrocarbon group; Y is a group of the formula: -OR3 (wherein R3 is a hydrogen atom, an optionally substituted hydrocarbon group, an optionally substituted heterocyclic group or an optionally substituted acyl group) or an optionally esterified or amidated carboxyl group, or a salt thereof or a prodrug thereof has a superior insulin secretion promoting action and a hypoglycemic action and shows low toxicity. Therefore, the compound is useful as a pharmaceutical agent, particularly as an agent for the prophylaxis or treatment of diabetes and diabetic complications, and the like.

  由式（I）代表的化合物 其中 R1 和 R2 中的一个是氢原子或取代基，另一个是任选取代的环状基团； W 是键或二价脂族烃基； Y 是式中的一个基团：-OR3（其中 R3 是氢原子、任选取代的烃基、任选取代的杂环基或任选取代的酰基）或任选酯化或酰胺化的羧基，或其盐或其原药具有优异的促进胰岛素分泌作用和降血糖作用，且毒性低。因此，该化合物可用作药物制剂，特别是用于预防或治疗糖尿病和糖尿病并发症等。
• Compositions comprising phenyl-glycine derivatives
  申请人：——

  公开号：US20030108496A1

  公开（公告）日：2003-06-12

  The invention relates to compositions and methods useful for treating a variety of cosmetic conditions and dermatological disorders, where the composition includes a phenyl glycine derivative represented by the following formula: 1 wherein, R 1 and R 2 are independently H, I, F, Cl, Br, OH, SH, NH 2 , NHNH 2 , alkyl, aralkyl, alkoxy, acetoxy, acyloxy group having 1 to 9 carbon atoms, and being attached at the 2, 3 or 4 position of the phenyl group, whereby when R 1 and/or R 2 are OH, SH, NH 2 , they may be acetylated or acylated with 1 to 9 carbon atoms; R 3 is H, formyl, acetyl, propanoyl, acyl, alkyl, aralkyl or an aryl group having 1 to 9 carbon atoms; R 4 is OH, NH 2 , NHOH, NHNH 2 , or OR; where R is an alkyl, aralkyl or aryl group having 1 to 9 carbon atoms; the H attached to any carbon or nitrogen atom may be substituted by I, F, Cl, Br, OH, SH, NH 2 , NHNH 2 , an alkyl, aralkyl, alkoxy or acyl group having 1 to 9 carbon atoms. Phenyl-glycine and its derivatives may be present as isomeric D or L, non-isomeric or racemic DL, as a free acid, salt, lactone, amide or ester form.

  本发明涉及用于治疗各种美容病症和皮肤病的组合物和方法，其中组合物包括由下式表示的苯基甘氨酸衍生物： 1 其中，R 1 和 R 2 独立地为 H、I、F、Cl、Br、OH、SH、NH 2 、NHNH 2 烷基、芳烷基、烷氧基、乙酰氧基、具有 1 至 9 个碳原子的酰氧基，且连接在苯基的 2、3 或 4 位，其中当 R 1 和/或 R 2 是 OH、SH、NH 2 它们可以是乙酰化的，也可以是带有 1 至 9 个碳原子的酰化的；R 3 是 H、甲酰基、乙酰基、丙酰基、酰基、烷基、芳基或具有 1 至 9 个碳原子的芳基；R 4 是 OH、NH 2 、NHOH、NHNH 2 或 OR；其中 R 是具有 1 至 9 个碳原子的烷基、芳基或芳基；与任何碳原子或氮原子相连的 H 可被 I、F、Cl、Br、OH、SH、NH 2 、NHNH 2 1 至 9 个碳原子的烷基、芳基、烷氧基或酰基取代。苯基甘氨酸及其衍生物可以 D 或 L、非同分异构体或外消旋 DL、游离酸、盐、内酯、酰胺或酯的形式存在。